PHIBRO ANIMAL HEALTH CORP-A (PAHC) Stock Analyst Ratings
USA - NASDAQ:PAHC - US71742Q1067 - Common Stock
43.76 USD
+0.72 (+1.67%)
43.76 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 49% to PAHC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 33.32. This target is -23.86% below the current price.
PAHC was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about PAHC.
In the previous month the buy percentage consensus was at a similar level.
PAHC was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-08-29 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-07-07 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-06-25 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-08 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-10 | Barclays | Maintains | Underweight -> Underweight |
| 2024-12-17 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-12 | Barclays | Maintains | Underweight -> Underweight |
| 2024-09-10 | JP Morgan | Initiate | Neutral |
| 2024-08-30 | B of A Securities | Maintains | Underperform -> Underperform |
| 2024-05-10 | Barclays | Maintains | Underweight -> Underweight |
| 2023-11-09 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-09-01 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-08-31 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-29 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-07-27 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-05-04 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-02-09 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-12-21 | Roth Capital | Initiate | Buy |
| 2022-11-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-09-16 | Barclays | Maintains | Underweight |
| 2022-08-26 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-07-25 | Barclays | Downgrade | Equal-Weight -> Underweight |
| 2022-01-10 | Barclays | Upgrade | Underweight -> Equal-Weight |
| 2021-11-18 | Morgan Stanley | Initiate | Equal-Weight |
| 2021-07-07 | Barclays | Downgrade | Equal-Weight -> Underweight |
| 2021-05-13 | Morgan Stanley | Maintains | Underweight |
PHIBRO ANIMAL HEALTH CORP-A / PAHC FAQ
Can you provide the average price target for PHIBRO ANIMAL HEALTH CORP-A stock?
9 analysts have analysed PAHC and the average price target is 33.32 USD. This implies a price decrease of -23.86% is expected in the next year compared to the current price of 43.76.
How do analysts rate PHIBRO ANIMAL HEALTH CORP-A (PAHC)?
The consensus rating for PHIBRO ANIMAL HEALTH CORP-A (PAHC) is 48.8889 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
What is the number of analysts for PAHC stock?
The number of analysts covering PHIBRO ANIMAL HEALTH CORP-A (PAHC) is 9.